FILTRATION OF DIALYSATE USING AN ONLINE DIALYSATE FILTER

被引:28
作者
FRINAK, S
POLASCHEGG, HD
LEVIN, NW
POHLOD, DJ
DUMLER, F
SARAVOLATZ, LD
机构
[1] HENRY FORD HOSP,DIV NEPHROL & HYPERTENS,2799 W GRAND BLVD,DETROIT,MI 48202
[2] HENRY FORD HOSP,DIV INFECT DIS & HOSP EPIDEMIOL,DETROIT,MI 48202
[3] FRESENIUS AG,HOMBURG,GERMANY
关键词
DIALYSIS; DIALYSATE; FILTRATION; ENDOTOXIN; BACTERIA; PYROGENIC;
D O I
10.1177/039139889101401103
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Increased concerns about pyrogenic contamination of dialysate have led to the development of an on-line dialysate filtration system. Bacteriological testing of the system was performed (n = 6) by introducing bicarbonate concentrate contaminated with E. coli 026:B 6 (3 x 10(9) cfu/ml) into a dialysis machine equipped with a two-stage polysulfone filtration system. The bacterial concentration of the dialysate entering the filtration system was maintained above 10(6) cfu/ml and endotoxin levels ranged from 30-300 ng/ml during the 3-hour test period. Bacterial and endotoxin levels on the input side of the first-stage filter reached minimum concentrations of 5.4 x 10(9) cfu/ml and 30,000 ng/ml respectively. All output samples of filtered dialysate showed no bacterial growth and endotoxin levels were below the sensitivity (0.003 ng/ml) of the LAL assay. A dialysis machine (QD = 500), equipped with a single stage filtration system, was used for 18 months of clinical testing. In order to evaluate the system's reliability with regard to membrane failures and reduced dialysate flow, filter membrane integrity was verified weekly using a pressure holding test and dialysate flow was measured under routine clinical conditions. No membrane failures occurred, and dialysate flow was maintained at 511 +/- 17 ml/min (n = 70) during the test period. In conclusion: dialysate filtration is an effective and practical method for prevention of pyrogenic reactions due to high levels of bacteria and endotoxins.
引用
收藏
页码:691 / 697
页数:7
相关论文
共 15 条
[1]  
BLAND L, 1987, T AM SOC ART INT ORG, V33, P542
[2]  
BOMMER J, 1987, CLIN NEPHROL, V27, P278
[3]   HEMODIAFILTRATION USING DIALYSATE AS SUBSTITUTION FLUID [J].
CANAUD, B ;
NGUYEN, QV ;
ARGILES, A ;
POLITO, C ;
POLASCHEOO, HD ;
MION, C .
ARTIFICIAL ORGANS, 1987, 11 (02) :188-190
[4]  
EBBEN J, 1987, T AM SOC ART INT ORG, V33, P269
[5]  
ERLEY CM, 1988, T AM SOC ART INT ORG, V34, P205
[6]  
GOULD MC, 1984, TISSUE CULTURE ASS M, V5, P125
[7]  
Klinkmann H, 1985, Contrib Nephrol, V46, P174
[8]  
Man N K, 1988, Contrib Nephrol, V62, P24
[9]  
MILLER JH, 1984, T AM SOC ART INT ORG, V30, P377
[10]  
POLASCHEGG HD, 1989, Patent No. 4834888